A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany
Clinical trial NCT07549516 · RECRUITING
Trial details
- NCT number
- NCT07549516
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-17
- Primary completion
- 2030-09-30
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.